Privia Health Group, Inc. (PRVA) Tops Q3 EPS by 15c, provides guidance

Privia Health Group, Inc. (NASDAQ: PRVA) reported Q3 EPS of $0.20, $0.15 better than the analyst estimate of $0.05. Revenue for the quarter came in at $437.9 million versus the consensus estimate of $414.17 million.

GUIDANCE:

Privia Health Group, Inc. sees FY2024 revenue of $1.675 billion, versus the consensus of $1.67 billion.

For earnings history and earnings-related data on Privia Health Group, Inc. (PRVA) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Edgewell stock surges on report of rejected takeover bid
• Boeing wins $121 million Navy contract for P-8A upgrades